Dedifferentiated Liposarcoma Clinical Trials

23 clinical trials for Dedifferentiated Liposarcoma across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) — RECRUITING · PHASE1
• STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas — RECRUITING · PHASE1
• A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors — RECRUITING · PHASE1
• A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas — RECRUITING · PHASE1
• A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma — RECRUITING · PHASE1
• A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI) — RECRUITING · PHASE2
• Efficacité et Tolérance de la Plitidepsine chez les patients souffrant d’un liposarcome dédifférencié (DLPS) avancé, non opérable ou métastatique, en rechute/réfractaire : Une étude exploratoire multicentrique de phase II. — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma — NOT_YET_RECRUITING · PHASE2
• Study of Abemaciclib in Dedifferentiated Liposarcoma — ACTIVE_NOT_RECRUITING · PHASE2
• Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery — ACTIVE_NOT_RECRUITING · PHASE2
• TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma — TERMINATED · PHASE2
• A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma — ACTIVE_NOT_RECRUITING · PHASE2
• Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas — COMPLETED · PHASE1
• Real-world Study of Dedifferentiated Liposarcoma Patients in China — COMPLETED
• Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma — TERMINATED · PHASE3
• Brightline-4: A Phase III open-label, single-arm, multi-center study to assess the safety and efficacy of brigimadlin (BI 907828) treatment in patients with treatment-naïve or pre-treated advanced dedifferentiated liposarcoma — OTHER · PHASE3
• First-line Treatment of Advanced/unresectable DDLPS — NOT_YET_RECRUITING · PHASE2
• Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors — TERMINATED · PHASE1
• Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma — NOT_YET_RECRUITING · NA
• Selinexor in Advanced Liposarcoma — COMPLETED · PHASE2
• Ph II Cabazitaxel DD Liposarcoma — COMPLETED · PHASE2
• Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall — OTHER · PHASE2
• Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma — WITHDRAWN · PHASE2

Refine this search